Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

NCT00548691 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

513

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Ferric Carboxymaltose
DRUG: Standard Medical Care (SMC)

Sponsor

American Regent, Inc.